OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Consensus Statement on Mandatory Measurements for Pancreatic Cancer Trials for Patients With Resectable or Borderline Resectable Disease (COMM-PACT-RB)
Esther N. Pijnappel, J. Annelie Suurmeijer, Bas Groot Koerkamp, et al.
JAMA Oncology (2022) Vol. 8, Iss. 6, pp. 929-929
Open Access | Times Cited: 6
Esther N. Pijnappel, J. Annelie Suurmeijer, Bas Groot Koerkamp, et al.
JAMA Oncology (2022) Vol. 8, Iss. 6, pp. 929-929
Open Access | Times Cited: 6
Showing 6 citing articles:
Clinical Efficacy of Neoadjuvant Chemotherapy with Gemcitabine plus S-1 for Resectable Pancreatic Ductal Adenocarcinoma Compared with Upfront Surgery
Yuki Kitano, Yosuke Inoue, Tsuyoshi Takeda, et al.
Annals of Surgical Oncology (2023) Vol. 30, Iss. 8, pp. 5093-5102
Closed Access | Times Cited: 5
Yuki Kitano, Yosuke Inoue, Tsuyoshi Takeda, et al.
Annals of Surgical Oncology (2023) Vol. 30, Iss. 8, pp. 5093-5102
Closed Access | Times Cited: 5
Association of Long-Term, New-Onset, and Postsurgical Diabetes With Survival in Patients With Resectable Pancreatic Cancer
Sarah Kanbour, Gayane Yenokyan, Mohammed S. Abusamaan, et al.
Pancreas (2023) Vol. 52, Iss. 6, pp. e309-e314
Open Access | Times Cited: 1
Sarah Kanbour, Gayane Yenokyan, Mohammed S. Abusamaan, et al.
Pancreas (2023) Vol. 52, Iss. 6, pp. e309-e314
Open Access | Times Cited: 1
Surgical Complications After Neoadjuvant Treatment for Borderline Resectable Pancreatic Cancer: From Benchmarks to Randomized Clinical Trials
Kjetil Søreide, Patrik Larsson, Sanjay Pandanaboyana
Annals of Surgical Oncology (2024)
Open Access
Kjetil Søreide, Patrik Larsson, Sanjay Pandanaboyana
Annals of Surgical Oncology (2024)
Open Access
Accuracy analysis of different dose calculation algorithms for locally advanced pancreatic cancer stereotactic body radiotherapy
Yongchun Song, Xuyao Yu, Yuwen Wang, et al.
Journal of Cancer (2023) Vol. 14, Iss. 14, pp. 2694-2699
Open Access
Yongchun Song, Xuyao Yu, Yuwen Wang, et al.
Journal of Cancer (2023) Vol. 14, Iss. 14, pp. 2694-2699
Open Access
Is the Delphi’s Oracle Pertinent to Patients With Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma?—Reply
J. Annelie Suurmeijer, Marc G. Besselink, Hanneke W.M. van Laarhoven
JAMA Oncology (2022) Vol. 8, Iss. 12, pp. 1851-1851
Closed Access
J. Annelie Suurmeijer, Marc G. Besselink, Hanneke W.M. van Laarhoven
JAMA Oncology (2022) Vol. 8, Iss. 12, pp. 1851-1851
Closed Access
Is the Delphi’s Oracle Pertinent to Patients With Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma?
Michele Reni, Marina Macchini, Giulia Orsi
JAMA Oncology (2022) Vol. 8, Iss. 12, pp. 1851-1851
Closed Access
Michele Reni, Marina Macchini, Giulia Orsi
JAMA Oncology (2022) Vol. 8, Iss. 12, pp. 1851-1851
Closed Access
